Fabtech Technologies CFO Kalpesh Chauhan Steps Down Effective November 12, 2026

Market snapshot: Fabtech Technologies Limited announced that Chief Financial Officer Kalpesh Chauhan will vacate his position on November 12, 2026. The departure is attributed to personal and professional reasons, marking a key leadership transition within the pharma engineering company.

Data Snapshot

• Chief Financial Officer Kalpesh Chauhan to leave position on November 12, 2026
• Q2 FY27 consolidated revenue reached ₹92.09 crore, up 22.8% sequentially
• Consolidated EBITDA for Q2 FY27 stood at ₹15.57 crore
• Total active consolidated order book stands above ₹900 crore

What's Changed

• Key Managerial Personnel transition initiated following the formal resignation of Chief Financial Officer Kalpesh Chauhan.

Key Takeaways

• CFO Kalpesh Chauhan will relinquish his duties on November 12, 2026, citing personal and professional reasons.
• The leadership transition comes shortly after the company reported Q2 FY27 revenue of ₹92.09 crore and EBITDA of ₹15.57 crore.
• Operational pipeline remains anchored by a consolidated order book exceeding ₹900 crore across international pharma infrastructure projects.
• The market will monitor the appointment of a successor CFO to evaluate governance and financial oversight continuity.

SAHI Perspective

Executive exits at the Key Managerial Personnel level require operational oversight to ensure uninterrupted financial oversight. Given Fabtech Technologies' active project execution across international markets and an order book above ₹900 crore, timely appointment of a qualified CFO successor remains critical for financial strategy execution.

Market Implications

Key managerial personnel changes often generate short-term market monitoring around compliance and strategic continuity. Investors will look for official board disclosures regarding interim or permanent CFO appointments under SEBI LODR norms.

Trading Signals

Market Bias: Neutral

The executive exit presents a neutral structural change. Strong underlying operational metrics, including Q2 FY27 revenue of ₹92.09 crore and an order book of ₹900 crore, buffer execution capabilities during the CFO replacement process.

Overweight: Pharma Engineering & Infrastructure

Trigger Factors:

• Board notification of new CFO appointment
• Filing of transition disclosure under SEBI Regulation 30

Time Horizon: Near-term (0-3 months)

Industry Context

Turnkey pharmaceutical engineering and cleanroom turnkey contracts rely heavily on precise project accounting and working capital management. Transition management in financial leadership is vital to maintain capital allocation standards across complex engineering cycles.

Key Risks to Watch

• Interim delay in appointing a permanent Chief Financial Officer.
• Governance oversight adjustments during peak execution of international projects.

Recent Developments

Fabtech Technologies declared Q2 FY27 financial results on October 28, 2026, posting consolidated revenue of ₹92.09 crore and EBITDA of ₹15.57 crore. Additionally, its step-down subsidiary completed a 14,000 sq. metre facility in Dubai for Himalaya Wellness Company in September 2026.

Closing Insight

While Key Managerial Personnel changes induce temporary focus on administrative continuity, Fabtech's grounded operational order book provides financial stability as management navigates the leadership transition.

High Performance Trading with SAHI.